search
Back to results

Neurally Adjusted Ventilatory Assist (NAVA) vs. Pressure Support in Pediatric Acute Respiratory Failure (NiNAVAped)

Primary Purpose

Pediatric Acute Respiratory Failure

Status
Unknown status
Phase
Phase 4
Locations
Spain
Study Type
Interventional
Intervention
Non invasive ventilation
Sponsored by
Hospital Universitario La Paz
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional supportive care trial for Pediatric Acute Respiratory Failure focused on measuring Positive Pressure Ventilation, Neurally Adjusted Ventilatory Assist, Patient/ventilator Asynchrony, Pediatric patient, Infant

Eligibility Criteria

1 Month - 18 Years (Child, Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  1. Age > 1 month age or weight > 3 Kg to 18 years
  2. Not intubated.
  3. Admitted to the PICU.
  4. Minimally agitated/sedated: between -2 and +2 on the Richmond agitation-sedation scale (Table 2).
  5. Moderate/severe Pediatric Acute Respiratory failure of any origin evaluated after a period of respiratory stabilization (aspiration of secretions, physiotherapy, oxygen and nebulized therapy) defined as: a) Modified Silverman-Wood Downess test >or= 5 or <or= 9; b) Hypoxemic ARF(SpO2< 94% FiO2 0,5). c)Hypercapnic ARF (PaCO2 (mmHg) and/or pH <7,30)
  6. The attending pediatric intensive care physician believes that the patient is likely to require endotracheal intubation (ETI).

Exclusion Criteria:

  1. Patients younger than 1 month or older than 18 year
  2. Severe ARF defined as Modified Silverman-Wood Downes test >9.
  3. Patients who need immediate endotracheal intubation: i.e.: Severe ARF with signs of exhaustion
  4. Facial trauma/burns
  5. Recent facial, upper way, or upper gastrointestinal tract surgery excepting gastrostomy for feeding
  6. Fixed obstruction of the upper airway.
  7. Inability to protect airway
  8. Life threatening hypoxemia defined as SpaO2 <90% with FiO2 > 0.8 on hi-flow oxygen.
  9. Hemodynamic instability: refractory at volume expansion >60 ml/kg and dopamine >10 mcg/kg/min
  10. Impaired consciousness defined as Glasgow coma scale < 10.
  11. Bowel obstruction.
  12. Untreated pneumothorax.
  13. Poor short term prognosis (high risk of death in the next 3 months)
  14. Known esophageal problem (hiatal hernia, esophageal varicosities)
  15. Active upper gastro-intestinal bleeding or any other contraindication to the insertion of a NG tube.
  16. Neuromuscular disease
  17. Vomiting
  18. Cough or gag reflex impairment.

18. Cyanotic congenital heart disease. 19. Complete absence of cooperation 20. This patient has previously been randomized in the study. 21. Repeated extubation failures (>or= 2).

Sites / Locations

  • Hospital Universitario La PazRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Active Comparator

Active Comparator

Arm Label

NIV PS

NIV NAVA

Arm Description

The patients in this arms will received non invasive ventilation in PS mode.

The patients in this arm will received non invasive ventilation in NAVA mode.

Outcomes

Primary Outcome Measures

Avoiding endotracheal intubation
The primary objective of this study is to demonstrate that the use of NAVA to provide noninvasive ventilatory support (NIV NAVA) compared to pressure support (NIV PS) in pediatric patients with moderate to severe respiratory failure decreases the noninvasive ventilation failure rate by decreasing the number of patients requiring endotracheal intubation (ETI).

Secondary Outcome Measures

Length (days) of PICU stay after NIV
Length (days) hospital stay after NIV

Full Information

First Posted
June 6, 2013
Last Updated
April 15, 2014
Sponsor
Hospital Universitario La Paz
search

1. Study Identification

Unique Protocol Identification Number
NCT01873521
Brief Title
Neurally Adjusted Ventilatory Assist (NAVA) vs. Pressure Support in Pediatric Acute Respiratory Failure
Acronym
NiNAVAped
Official Title
A Multicentre, Randomized, Clinical Trial of Noninvasive Ventilation: Neurally Adjusted Ventilatory Assist (NAVA) vs. Pressure Support in Pediatric Acute Respiratory Failure - NINAVAPed Protocol
Study Type
Interventional

2. Study Status

Record Verification Date
April 2014
Overall Recruitment Status
Unknown status
Study Start Date
February 2014 (undefined)
Primary Completion Date
September 2014 (Anticipated)
Study Completion Date
December 2016 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Hospital Universitario La Paz

4. Oversight

Data Monitoring Committee
Yes

5. Study Description

Brief Summary
It is hypothesized that the use of Neurally Adjusted Ventilatory Assist (NAVA) compared to pressure support to provide noninvasive ventilation to children will result in a decrease in the number of children with moderate to severe respiratory failure failing noninvasive ventilation and requiring endotracheal intubation. It is further hypothesized that noninvasive ventilation with NAVA compared to pressure support will result in a decrease in the length of mechanical ventilation, and the length of PICU and hospital stay.
Detailed Description
Mechanical ventilation (MV) refers to the use of life-support technology to perform the work of breathing for patients who are unable to breathe on their own. One of the most common reasons for a Pediatric Intensive Care Unit (PICU) admission is the need for mechanical ventilation. However, MV is associated with increased morbidity (endotracheal intubation, tracheal edema, atelectasis, cardiovascular instability, ventilator-associated pneumonia, bleeding, pneumothorax, chronic lung disease, etc), a long length of stay in the PICU and high health care costs. Noninvasive ventilation (NIV) has become a primary approach to ventilatory support of patients of all ages and it is estimated that it can avoid endotracheal intubation and replace conventional mechanical ventilation in around 60% of patients with acute respiratory failure. NIV has been shown to ameliorate clinical signs of failure and improve gas exchange while reducing the need for endotracheal intubation (ETI) thus avoiding the risks associated with invasive ventilation. NIV has been shown to decrease the length of mechanical ventilation, the risk of ventilator associated pneumonia, the sedation requirement, the length of ICU and hospital stay and mortality, while improving the ability to tolerate enteral feeds. NIV does not increase beside caregiver time and does decrease cost. With children because of the difficulty in assuring the patient's cooperation, the lack of available high quality masks and the resulting size of the air leak, synchrony between the ventilatory pattern of the patient and the support provided by the ventilator is poor. This problem had lead to repeated failure of noninvasive ventilation in children. The primary mode of noninvasive ventilatory support is pressure support (NIV PS). This mode is triggered to inspiration and cycled to exhalation by changes in patient inspiratory gas flow. But with air leaks the ability of the ventilator to coordinate with the patient is decreased. A new mode of ventilation, Neurally Adjusted Ventilatory Assist (NAVA) has been recently introduced. This mode triggers, cycles and regulates gas delivery based on the diaphragmatic EMG signal via a specially designed nasogastric tube (Edi). As a result, air leaks do not affect the ability of the ventilator to synchronize gas delivery with the patient increasing patient ventilator synchrony. Based on the operation of NAVA it is expected to increase the successful application of noninvasive ventilation to children.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Pediatric Acute Respiratory Failure
Keywords
Positive Pressure Ventilation, Neurally Adjusted Ventilatory Assist, Patient/ventilator Asynchrony, Pediatric patient, Infant

7. Study Design

Primary Purpose
Supportive Care
Study Phase
Phase 4
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
350 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
NIV PS
Arm Type
Active Comparator
Arm Description
The patients in this arms will received non invasive ventilation in PS mode.
Arm Title
NIV NAVA
Arm Type
Active Comparator
Arm Description
The patients in this arm will received non invasive ventilation in NAVA mode.
Intervention Type
Procedure
Intervention Name(s)
Non invasive ventilation
Primary Outcome Measure Information:
Title
Avoiding endotracheal intubation
Description
The primary objective of this study is to demonstrate that the use of NAVA to provide noninvasive ventilatory support (NIV NAVA) compared to pressure support (NIV PS) in pediatric patients with moderate to severe respiratory failure decreases the noninvasive ventilation failure rate by decreasing the number of patients requiring endotracheal intubation (ETI).
Time Frame
During non invasive ventilation, an average of 2-3 days.
Secondary Outcome Measure Information:
Title
Length (days) of PICU stay after NIV
Time Frame
Length (days) of PICU stay after NIV, an average of 1 week.
Title
Length (days) hospital stay after NIV
Time Frame
Length (days) hospital stay after NIV, an average of 1-2 weeks

10. Eligibility

Sex
All
Minimum Age & Unit of Time
1 Month
Maximum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Age > 1 month age or weight > 3 Kg to 18 years Not intubated. Admitted to the PICU. Minimally agitated/sedated: between -2 and +2 on the Richmond agitation-sedation scale (Table 2). Moderate/severe Pediatric Acute Respiratory failure of any origin evaluated after a period of respiratory stabilization (aspiration of secretions, physiotherapy, oxygen and nebulized therapy) defined as: a) Modified Silverman-Wood Downess test >or= 5 or <or= 9; b) Hypoxemic ARF(SpO2< 94% FiO2 0,5). c)Hypercapnic ARF (PaCO2 (mmHg) and/or pH <7,30) The attending pediatric intensive care physician believes that the patient is likely to require endotracheal intubation (ETI). Exclusion Criteria: Patients younger than 1 month or older than 18 year Severe ARF defined as Modified Silverman-Wood Downes test >9. Patients who need immediate endotracheal intubation: i.e.: Severe ARF with signs of exhaustion Facial trauma/burns Recent facial, upper way, or upper gastrointestinal tract surgery excepting gastrostomy for feeding Fixed obstruction of the upper airway. Inability to protect airway Life threatening hypoxemia defined as SpaO2 <90% with FiO2 > 0.8 on hi-flow oxygen. Hemodynamic instability: refractory at volume expansion >60 ml/kg and dopamine >10 mcg/kg/min Impaired consciousness defined as Glasgow coma scale < 10. Bowel obstruction. Untreated pneumothorax. Poor short term prognosis (high risk of death in the next 3 months) Known esophageal problem (hiatal hernia, esophageal varicosities) Active upper gastro-intestinal bleeding or any other contraindication to the insertion of a NG tube. Neuromuscular disease Vomiting Cough or gag reflex impairment. 18. Cyanotic congenital heart disease. 19. Complete absence of cooperation 20. This patient has previously been randomized in the study. 21. Repeated extubation failures (>or= 2).
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Pedro De la Oliva, MD, PhD
Phone
+34917277149
Email
pedro.oliva@salud.madrid.org
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Robert M Kacmarek, PhD RRT FCCM
Organizational Affiliation
Massachusetts General Hospital, Boston, USA
Official's Role
Study Director
First Name & Middle Initial & Last Name & Degree
Jesús Villar, MD,PhD
Organizational Affiliation
Hospital Universitario Dr. Negrin
Official's Role
Principal Investigator
Facility Information:
Facility Name
Hospital Universitario La Paz
City
Madrid
ZIP/Postal Code
28046
Country
Spain
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Pedro De la Oliva, MD,PhD
Phone
+34917277149
Email
pedro.oliva@salud.madrid.org
First Name & Middle Initial & Last Name & Degree
Pedro De la Oliva, MD,PhD
First Name & Middle Initial & Last Name & Degree
Ana Gómez-Zamora, MD
First Name & Middle Initial & Last Name & Degree
Cristina Schüffelmann, MD

12. IPD Sharing Statement

Citations:
PubMed Identifier
12667269
Citation
Cheifetz IM. Invasive and noninvasive pediatric mechanical ventilation. Respir Care. 2003 Apr;48(4):442-53; discussion 453-8.
Results Reference
background
PubMed Identifier
14968216
Citation
Al-Mutairi SS, Al-Deen JS. Non-invasive positive pressure ventilation in acute respiratory failure. An alternative modality to invasive ventilation at a general hospital. Saudi Med J. 2004 Feb;25(2):190-4.
Results Reference
background
PubMed Identifier
9827833
Citation
L'HerE, Moriconi M, Texier F, Bouquin V, Kaba L, Renault A, Garo B, Boles JM. Non-invasive continuous positive airway pressure in acute hypoxaemic respiratory failure--experience of an emergency department. Eur J Emerg Med. 1998 Sep;5(3):313-8.
Results Reference
background
PubMed Identifier
16276332
Citation
Bernet V, Hug MI, Frey B. Predictive factors for the success of noninvasive mask ventilation in infants and children with acute respiratory failure. Pediatr Crit Care Med. 2005 Nov;6(6):660-4. doi: 10.1097/01.pcc.0000170612.16938.f6.
Results Reference
background
PubMed Identifier
15599160
Citation
Keenan SP, Sinuff T, Cook DJ, Hill NS. Does noninvasive positive pressure ventilation improve outcome in acute hypoxemic respiratory failure? A systematic review. Crit Care Med. 2004 Dec;32(12):2516-23. doi: 10.1097/01.ccm.0000148011.51681.e2.
Results Reference
background
PubMed Identifier
17290566
Citation
Kendirli T, Kavaz A, Yalaki Z, Ozturk Hismi B, Derelli E, Ince E. Mechanical ventilation in children. Turk J Pediatr. 2006 Oct-Dec;48(4):323-7.
Results Reference
background
PubMed Identifier
20440111
Citation
Calderini E, Chidini G, Pelosi P. What are the current indications for noninvasive ventilation in children? Curr Opin Anaesthesiol. 2010 Jun;23(3):368-74. doi: 10.1097/ACO.0b013e328339507b.
Results Reference
background
PubMed Identifier
18712350
Citation
Essouri S, Durand P, Chevret L, Haas V, Perot C, Clement A, Devictor D, Fauroux B. Physiological effects of noninvasive positive ventilation during acute moderate hypercapnic respiratory insufficiency in children. Intensive Care Med. 2008 Dec;34(12):2248-55. doi: 10.1007/s00134-008-1202-9. Epub 2008 Aug 19.
Results Reference
background
PubMed Identifier
19593246
Citation
Breatnach C, Conlon NP, Stack M, Healy M, O'Hare BP. A prospective crossover comparison of neurally adjusted ventilatory assist and pressure-support ventilation in a pediatric and neonatal intensive care unit population. Pediatr Crit Care Med. 2010 Jan;11(1):7-11. doi: 10.1097/PCC.0b013e3181b0630f.
Results Reference
background
PubMed Identifier
20828233
Citation
Biban P, Serra A, Polese G, Soffiati M, Santuz P. Neurally adjusted ventilatory assist: a new approach to mechanically ventilated infants. J Matern Fetal Neonatal Med. 2010 Oct;23 Suppl 3:38-40. doi: 10.3109/14767058.2010.510018.
Results Reference
background
PubMed Identifier
20308933
Citation
Munoz-Bonet JI, Flor-Macian EM, Brines J, Rosello-Millet PM, Cruz Llopis M, Lopez-Prats JL, Castillo S. Predictive factors for the outcome of noninvasive ventilation in pediatric acute respiratory failure. Pediatr Crit Care Med. 2010 Nov;11(6):675-80. doi: 10.1097/PCC.0b013e3181d8e303.
Results Reference
background

Learn more about this trial

Neurally Adjusted Ventilatory Assist (NAVA) vs. Pressure Support in Pediatric Acute Respiratory Failure

We'll reach out to this number within 24 hrs